C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2006
11/23/2006	CA2608636A1 Sequential cloning system
11/23/2006	CA2608498A1 Anti-gm-csf antibodies and uses therefor
11/23/2006	CA2608481A1 Piggybac as a tool for genetic manipulation and analysis in vertebrates
11/23/2006	CA2608004A1 Isolated aqdecay photoprotein and use thereof
11/23/2006	CA2607963A1 Method of identifying compounds that modulate interaction of androgen receptor with beta-catenin
11/23/2006	CA2607847A1 Post-transcriptional regulation of gene expression in plants
11/23/2006	CA2607305A1 Anti-mesothelin antibodies useful for immunological assays
11/23/2006	CA2607291A1 Compositions and methods for modulating immune responses
11/23/2006	CA2607072A1 Materials and methods for regulating blood flow
11/23/2006	CA2606576A1 High-level expression of recombinant antibody in a mammalian host cell
11/23/2006	CA2605508A1 Blockade of pin1 prevents cytokine production by activated immune cells
11/23/2006	CA2604452A1 Improved methods and devices for delivering a therapeutic product to the ocular sphere of a subject
11/23/2006	CA2597511A1 Hivcon: an hiv immunogen and uses thereof
11/23/2006	CA2591624A1 Pasteurella multocida vaccine
11/22/2006	EP1724588A2 Diagnostic screens for Alzheimer's disease
11/22/2006	EP1724361A1 Method for sufficiently detecting double-stranded nucleic acid
11/22/2006	EP1724355A2 Transgenic plants containing molecular decoys that alter protein content therein
11/22/2006	EP1724354A2 Circular DNA molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy
11/22/2006	EP1724353A2 Methods of forming protein-linked lipidic microparticles
11/22/2006	EP1724352A2 Specific nucleic acids and polypeptide from pathogenic strains of Neisseria
11/22/2006	EP1724351A2 Human Kallikrein-like genes
11/22/2006	EP1724350A1 Method and compositions for the diagnosis and treatment of cancer
11/22/2006	EP1724349A1 TIE Ligand Homologues
11/22/2006	EP1724348A2 Molecular tagging system
11/22/2006	EP1724347A2 DNA & protein binding miniature proteins
11/22/2006	EP1724346A2 Peptides binding to the Lck-SH3 and to the Hck-SH3 domain
11/22/2006	EP1724345A1 Method of detecting and identifying lactic acid bacterium
11/22/2006	EP1724344A1 Process for producing amino acid
11/22/2006	EP1724343A1 Dna enzyme and method of controlling the activity thereof
11/22/2006	EP1724342A1 Process for producing erysipelothrix rhusiopathiae surface protective antigen mutant in escherichia coli
11/22/2006	EP1724341A1 Novel taste sensation-modifying peptide nas, dna thereof and use of the same
11/22/2006	EP1724340A1 New antibiotic-sensitive lactic acid bacteria strains
11/22/2006	EP1724286A1 Variant CD44 polypeptide, polynucleotides encoding same, antibodies directed there against and method of using same for diagnosing and treating inflammatory diseases
11/22/2006	EP1724284A2 GLP-1 fusion proteins
11/22/2006	EP1724283A2 Corticotropin releasing factor receptor 2 agonists
11/22/2006	EP1724254A2 Novel compositions for the delivery of negatively charged molecules
11/22/2006	EP1724016A1 Ph dependent ion exchange material capable of selectively binding to nucleic acids, solid substrate having the material immobilized on its surface, and method of isolating a nucleic acid using the same
11/22/2006	EP1723964A1 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections
11/22/2006	EP1723950A2 Method of treating dopaminergic gaba-nergic disorders
11/22/2006	EP1723488A2 Glyphosate tolerant plants and methods of making and using the same
11/22/2006	EP1723417A1 C20orf23 as modifier of the igfr pathway and methods of use
11/22/2006	EP1723415A1 Pdes as modifiers of the igfr pathway and methods of use
11/22/2006	EP1723260A2 Nucleic acid representations utilizing type iib restriction endonuclease cleavage products
11/22/2006	EP1723255A2 Method for enrichment involving elimination by mismatch hybridisation
11/22/2006	EP1723253A2 Inhibitors of siderophore biosynthesis in fungi
11/22/2006	EP1723250A2 Functional genomics and gene trapping in haploid or hypodiploid cells
11/22/2006	EP1723247A1 Recombinant perforin, expression and uses thereof
11/22/2006	EP1723246A1 New expression tools for multiprotein applications
11/22/2006	EP1723245A2 Glutamine-rich maize seed protein and promoter
11/22/2006	EP1723244A2 Seeds
11/22/2006	EP1723243A1 Plants having improved yield and method for making the same
11/22/2006	EP1723242A2 Plants having increased yield and method for making the same
11/22/2006	EP1723241A1 Transgenic expression constructs for vegetative plant tissue specific expression of nucleic acids
11/22/2006	EP1723240A1 Culture device and method for eukaryotic cell transfection
11/22/2006	EP1723239A1 Method for generating tethered proteins
11/22/2006	EP1723238A1 Modified oncolytic viruses
11/22/2006	EP1723237A2 Use of genes encoding outward potassium channels for modifying at least one phenotype linked to the size and organic acid content of at least one plant storage organ
11/22/2006	EP1723236A1 Method for the recombinant expression of an n-terminal fragment of hepatocyte growth factor
11/22/2006	EP1723235A1 Modified cells that co-express blimp1 and a reporter molecule and methods of using the same
11/22/2006	EP1723234A1 Vglut-specific dsrna compounds
11/22/2006	EP1723233A1 Method for enriching and/or separating prokaryotic dna using a protein that specifically bonds to unmethylated dna containing cpg-motives
11/22/2006	EP1723232A1 Isolating, positioning, and sequencing single molecules
11/22/2006	EP1723231A1 A small synthetic rna, a method of preparing the same and uses thereof
11/22/2006	EP1723230A1 Altered expression in filamentous fungi
11/22/2006	EP1723178A2 Human g-protein chemokine receptor (ccr5) hdgnr10
11/22/2006	EP1723177A2 Rab9a, rab11a, and modulators thereof related to infectious disease
11/22/2006	EP1723174A1 A novel modulator of glucocorticoid receptor activities
11/22/2006	EP1723168A2 Beak and feather disease virus sequences, compositions and vaccines and the use thereof in therapy, diagnosis and assays
11/22/2006	EP1722823A2 Pharmaceutical composition
11/22/2006	EP1722808A2 Egf receptor epitode peptides and uses thereof
11/22/2006	EP1722760A2 Delivery of genes encoding short hairpin rna using receptor-specific nanocontainers
11/22/2006	EP1722624A1 Method for preparing transgenic pepper using callus induction
11/22/2006	EP1627064A4 Flowering inhibition
11/22/2006	EP1531692B1 Virulent phages to control listeria monocytogenes in foodstuffs and in food processing plants
11/22/2006	EP1516186A4 A method for the detection of apoptosis
11/22/2006	EP1468101B1 Process for preparing chiral aromatic alpha-hydroxy ketones using 2-hydroxy-3-oxoacid synthase
11/22/2006	EP1445609B1 Base sequencing electrode, base sequencing device and base sequencing method
11/22/2006	EP1373571B1 Functional surface display of polypeptides
11/22/2006	EP1360306B1 Dna sequence of the enzyme phospholipase a1 of ciliate tetrahymena, and the use of the same
11/22/2006	EP1309342B1 Production of a chimeric human papillomavirus
11/22/2006	EP1283668B1 Nucleic acids that control plant development
11/22/2006	EP1266025B1 Protein scaffolds for antibody mimics and other binding proteins
11/22/2006	EP1263781B1 Viral antigen and vaccine against isav (infectious salmon anaemia virus)
11/22/2006	EP1244651B1 Diamidine compounds as dna minor groove binders
11/22/2006	EP1218529B1 Reverse transfection method
11/22/2006	EP1214098B1 Capsid-modified recombinant adenovirus and methods of use
11/22/2006	EP1173465B1 Novel human voltage-gated potassium channel
11/22/2006	EP1163522B1 Method for detecting msrv-1 induced superantigen activity in a biological sample
11/22/2006	EP1147222B1 Replicable probe array
11/22/2006	EP1078054B1 Monomeric mp52/gdf-5 with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone
11/22/2006	EP1071774B1 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof
11/22/2006	EP1053309B1 Compositions and methods for wound healing
11/22/2006	EP1037603B1 Membrane virus host range mutations and their uses as vaccine substrates
11/22/2006	EP1000168B1 A swine hepatitis e virus and uses thereof
11/22/2006	EP1000158B1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders
11/22/2006	EP0999273B1 HUMAN GENE RecQ4 ENCODING HELICASE
11/22/2006	EP0939821B1 G-beta-gamma regulated phosphatidylinositol-3' kinase
11/22/2006	EP0935415B1 In vitro methods for delivering nucleic acids into a cell
11/22/2006	EP0890105B1 Methods related to Alzheimer's disease for diagnosis, manufacture of medicaments and screening of substances and beta-amyloid related peptides
11/22/2006	EP0885296B1 An enzyme with galactanase activity

1 ... 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 ... 4023